Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Properties of Heavy Cosmic Nuclei Phosphorus, Chlorine, Argon, Potassium, and Calcium: Results from the Alpha Magnetic Spectrometer.

Physical review letters·2026
Same author

Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged ≥65: a study from the ALWP of EBMT.

Bone marrow transplantation·2026
Same author

Antibacterial prophylaxis and antimicrobial stewardship in the era of innovative therapies for haematological malignancies: transplantation, cellular therapies and new drugs.

JAC-antimicrobial resistance·2026
Same author

Exploring the utility and limitations of ChatGPT in scientific literature searches.

ESMO real world data and digital oncology·2026
Same author

Response to Letter to the Editor Re: Impact of the Prosigna assay on neoadjuvant treatment decision making in patients with early-stage HR-positive/HER2-negative breast cancer: a single-center prospective observational study.

ESMO open·2025
Same author

Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendations.

Bone marrow transplantation·2025

Related Experiment Video

Updated: Apr 11, 2026

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

14.3K

Haploidentical HSCT: a 15-year experience at San Raffaele.

C Bonini1, J Peccatori2, M T L Stanghellini2

  • 1Experimental Hematology Unit, San Raffaele Scientific Institute, Milan, Italy.

Bone Marrow Transplantation
|June 4, 2015
PubMed
Summary
This summary is machine-generated.

Haploidentical stem cell transplants improve immune recovery and control GvHD in high-risk leukemia. Strategies include genetically modified T cells and novel GvHD prophylaxis for safer transplantation.

More Related Videos

Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration
10:03

Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration

Published on: January 20, 2014

10.2K
Purification and Expansion of Mouse Invariant Natural Killer T Cells for in vitro and in vivo Studies
08:37

Purification and Expansion of Mouse Invariant Natural Killer T Cells for in vitro and in vivo Studies

Published on: February 15, 2021

5.0K

Related Experiment Videos

Last Updated: Apr 11, 2026

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

14.3K
Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration
10:03

Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration

Published on: January 20, 2014

10.2K
Purification and Expansion of Mouse Invariant Natural Killer T Cells for in vitro and in vivo Studies
08:37

Purification and Expansion of Mouse Invariant Natural Killer T Cells for in vitro and in vivo Studies

Published on: February 15, 2021

5.0K

Area of Science:

  • Hematology
  • Immunology
  • Transplant Medicine

Background:

  • Hematopoietic stem cell transplantation (HSCT) is crucial for high-risk hematological malignancies.
  • HLA haploidentical family donors offer a viable HSCT source.
  • San Raffaele Scientific Institute has 15 years of experience in HSCT platforms and cellular interventions.

Purpose of the Study:

  • To review HSCT strategies for hematological malignancies.
  • To present findings on T cell-depleted haploidentical HSCT with genetically modified T cells.
  • To discuss novel GvHD prophylaxis for unmanipulated PBSC transplants.

Main Methods:

  • Investigated T cell-depleted haploidentical HSCT with genetically modified donor T cells (TK007 study).
  • Conducted a phase III multicenter randomized trial (TK008 study) for this approach.
  • Employed sirolimus-based, calcineurin inhibitor-free GvHD prophylaxis for unmanipulated PBSC transplants (TrRaMM study).

Main Results:

  • T cell-depleted haploidentical HSCT with modified T cells promotes rapid immune reconstitution.
  • This approach effectively controls GvHD.
  • Sirolimus-based prophylaxis enables safe infusion of unmanipulated PBSCs from haploidentical donors.

Conclusions:

  • Haploidentical HSCT is a promising therapy for high-risk hematological malignancies.
  • Genetically modified T cells enhance immune recovery and GvHD control post-transplant.
  • Novel GvHD prophylaxis strategies expand transplant options using haploidentical donors.